International Immunology Advance Access published online on November 1, 2004
International Immunology, doi:10.1093/intimm/dxh180
© 2004 by The Japanese Society for Immunology
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Center for Immunology and Department of Molecular Biology and Biochemistry, University of California, Irvine, CA, USA
* To whom correspondence should be addressed. The signaling enzyme phosphoinositide 3-kinase (PI3K) is activated following B cell receptor (BCR) engagement and by many other receptors on B lymphocytes. Mice lacking p85
Accepted September 28, 2004
Article
Altered splenic B cell subset development in mice lacking phosphoinositide 3-kinase p85
David A. Fruman, E-mail: dfruman{at}uci.edu
![]()
Abstract
, the predominant PI3K regulatory isoform, exhibit defects in B cell development and activation that are grossly similar to those found in mice lacking Bruton's tyrosine kinase (Btk) and other critical signaling molecules. However, a detailed analysis of splenic B cell subsets in p85
-deficient mice has not been reported. Here we show that these mice are deficient in four major B cell subsets: transitional-1, transitional-2, follicular and marginal zone. These defects are distinct from those observed in Xid mice that express a mutant Btk unable to interact with PI3K lipid products. Moreover, mice with both genetic lesions exhibit even greater impairment in B cell development. Finally, we show that transgenic expression of the anti-apoptotic protein Bcl-2 in p85
-deficient mice restores the transitional B cell subsets but not the marginal zone subset, and produces a follicular population with an aberrant phenotype. These findings establish a role for PI3K-p85
in differentiation of both follicular and marginal zone B cells, and suggest that these functions are required not solely for the propagation of anti-apoptotic signals.![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. L. Janas, D. Hodson, Z. Stamataki, S. Hill, K. Welch, L. Gambardella, L. C. Trotman, P. P. Pandolfi, E. Vigorito, and M. Turner The Effect of Deleting p110{delta} on the Phenotype and Function of PTEN-Deficient B Cells J. Immunol., January 15, 2008; 180(2): 739 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Matheu, J. A. Deane, I. Parker, D. A. Fruman, and M. D. Cahalan Class IA Phosphoinositide 3-Kinase Modulates Basal Lymphocyte Motility in the Lymph Node J. Immunol., August 15, 2007; 179(4): 2261 - 2269. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Verkoczy, B. Duong, P. Skog, D. Ait-Azzouzene, K. Puri, J. L. Vela, and D. Nemazee Basal B Cell Receptor-Directed Phosphatidylinositol 3-Kinase Signaling Turns Off RAGs and Promotes B Cell-Positive Selection J. Immunol., May 15, 2007; 178(10): 6332 - 6341. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Gustin, C. K. Korgaonkar, R. Pincheira, Q. Li, and D. B. Donner Akt Regulates Basal and Induced Processing of NF-{kappa}B2 (p100) to p52 J. Biol. Chem., June 16, 2006; 281(24): 16473 - 16481. [Abstract] [Full Text] [PDF] |
||||

